0
Editorial |

Imaging of Pulmonary Embolism: Title and subTitle BreakToo Much of a Good Thing?

Jeffrey Glassroth, MD
[+] Author Affiliations

Author Affiliations: Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

More Author Information
JAMA. 2007;298(23):2788-2789. doi:10.1001/jama.298.23.2788
Text Size: A A A
Published online

The study by Anderson and colleagues1 in this issue of JAMA convincingly demonstrates that computed tomographic pulmonary angiography (CTPA) is not inferior to ventilation-perfusion (/) lung scanning for the exclusion of pulmonary embolism (PE). Confirmation on this point is comforting because CTPA has had a wide range of sensitivities reported for detection of PE2 but nevertheless has largely supplanted /scanning for several years for this purpose.3

This study is also notable for a number of additional reasons. First, the investigators' study design and management algorithms use D-dimer testing,4 structured pretest probability (of PE) assessment,5 and venous ultrasound of the lower extremities to identify deep venous thrombosis. In essence, the study represented a unique head-to-head comparison of / scanning and CTPA conducted in a manner that duplicated real-world best-practice conditions. Moreover, because this was a multicenter randomized study with a large number of participants, these results can be confidently generalized. In addition, a large proportion of study participants having a technically adequate CTPA study (73%) were imaged using a multidetector CT scanner. This fact is important because multidetector-row CT is rapidly supplanting single-slice CTPA, in part as a technological response to concerns that single-slice scanners were relatively insensitive to and missed small clots in the distal (ie, subsegmental) pulmonary vasculature.6 Indeed, one of the principal arguments against the general use of earlier generation CTPA for the exclusion of PE was a perceived lack of sensitivity for detecting such clots.7 The study by Anderson and colleagues1 indicates that this is no longer an issue, at least at the level of detection of /scanning, long the first-line imaging technique for this purpose.

As often happens with research, this new study raises some additional and important questions. Chief among these is whether CTPA, if not inferior to /, is it actually superior or even too good as a first-line imaging modality for patients suspected of having PE? Consider the implications of state-of-the art CTPA scanning. On the positive side, in addition to sensitivity, CTPA has good interreader agreement,8 is highly specific for pulmonary emboli,6 ,9 and eliminates some of the subjectivity and confusion associated with / scan interpretation expressed in probabilities of PE. Computed tomographic pulmonary angiography can also identify alternative explanations for symptoms even as emboli are excluded10 and may provide additional important clinical information on the cardiac impact of emboli that can guide management decisions.11

Less desirable attributes of CTPA are the requirement for dye with its attendant risk of allergic reactions and contrast nephropathy and the substantially greater radiation exposure of CTPA compared with / scanning.12 A more subtle issue is also raised by the data reported by Anderson et al. Specifically, CTPA may well lead to more diagnoses of PE than / scanning. This is suggested by significantly more patients in the CTPA group than the / scan group being diagnosed with PE (a statistically significant difference) and by the fact that several patients who crossed over to CTPA after having PE excluded by / scanning were found to have PE. Why might this be a problem? Hypothetically, if CTPA identifies clots that are not likely to be of clinical significance and if patients with such clots are then treated for them, these patients are being unnecessarily exposed to the risks of anticoagulation and to the implications of carrying a history of PE. Moreover, society has to deal with the considerable costs associated with all of this.

Is it possible to have clinically insignificant PE? Presumably, the clots most likely to be insignificant would be small and would involve only a relatively small proportion of the distal pulmonary vasculature. Indeed, about 7% of the patients diagnosed with emboli using CTPA by Anderson and colleagues had isolated subsegmental pulmonary artery involvement. This is similar to the distribution reported in other studies13 - 14 However, complicating matters is an analysis indicating that patients with such clots may have a very different clinical presentation than patients with larger clots; they are less likely to have new or worsening dyspnea, or to have proximal deep vein thrombosis detected by ultrasonography and are more likely to be assigned a low clinical (ie, pretest) probability of having PE.15 Such patients are also more likely to have negative D-dimer assays.16 This profile might well have caused such patients to have been overlooked or excluded from many studies of PE and possibly to be undercounted; the 7% estimate of subsegmental vessel emboli may well be an underestimate.

So just how risky are isolated subsegmental pulmonary emboli? Two recent reviews have assessed the limited available data addressing this issue.15 ,17 They suggest that a subset of patients with good cardiopulmonary reserve, no evident deep vein thrombosis, and limited predisposition to subsequent thromboembolism may not require anticoagulation for isolated subsegmental PE. However, overlooking potentially significant pulmonary emboli carries its own set of issues as exemplified by the 8 participants in the study by Anderson et al, some of whom may have had clots missed by CTPA or / scanning but who subsequently developed evident venous thromboembolism including one fatal episode.

What are the clinical implications of these findings, and how should this information be considered in patient management decisions? First, clinicians should consider the likelihood of PE in a structured manner based on patients' presenting histories and physical examinations much the way Anderson and colleagues did, and based on those assessments, proceed, as necessary, to D-dimer testing. These 2 steps may substantially reduce the probability that PE, at least large clots, are present18 and obviate the need for additional study. Where significant concern remains, including some patients whose PE probability may not be very high but whose comorbidities put them at great risk were an embolism to occur, additional testing should be pursued. If readily available, lower extremity ultrasound studies to search for deep vein thrombosis to treat those patients found to have such clots is a reasonable next step. If deep vein thromboses are excluded or if ultrasound is not immediately available, then imaging of the chest is indicated. At the current state-of-the-art CTPA, using multidetector scanners, appears to be an excellent imaging choice unless there is a contraindication to dye administration or, perhaps, in pregnancy because of the higher dose of radiation with CTPA. For patients who cannot be studied by multidetector-row CTPA, / scanning would still be available. Of note, there is no evidence from the study by Anderson et al1 that single-detector scans are superior to / scan.

In addition, more in-depth understanding is needed about distal subsegmental clots. For example, what is the natural history of such clots? Do subsets of patients with such clots share easily identified characteristics that put them at higher or lower risk of adverse outcomes? Is there still a role for conventional angiography? Answers will require additional clinical studies, likely involving multiple centers given the relatively small proportion of patients affected. Whether or not to treat some of these patients will have to remain a decision made on a case-by-case basis for now.

Thirty years ago, Robin19 opined that “the emperor of embolism has no clothes” because overestimates of PE prevalence and underutilization of available diagnostics led to overdiagnosis. Today, diagnostics are better and likely to offer more accurate prevalence estimates, but clinicians may not know just what to do with all this information. Available technology and well-designed trials should, however, provide answers to important questions about PE. In that sense, perhaps, the emperor is now partially clothed.

AUTHOR INFORMATION

Corresponding Author: Jeffrey Glassroth, MD, Department of Medicine, Feinberg School of Medicine, Northwestern University, 303 E Chicago Ave, Ward 4-009, Chicago, IL 60611 (j-glassroth@northwestern.edu).

Financial Disclosures: None reported.

Editorials represent the opinions of the authors and JAMA and not those of the American Medical Association.

Anderson DR, Kahn SR, Rodger MA.  et al.  Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial.  JAMA. 2007;298(23):2743-2753
Eng J, Krishnan JA, Segal JB.  et al.  Accuracy of CT in the diagnosis of pulmonary embolism: a systematic literature review.  AJR Am J Roentgenol. 2004;183(6):1819-1827
PubMed
Strashun AM. A reduced role of V/Q scintigraphy in the diagnosis of acute pulmonary embolism.  J Nucl Med. 2007;48(9):1405-1407
PubMed
Stein PD, Hull RD, Patel KC.  et al.  D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review.  Ann Intern Med. 2004;140(8):589-602
PubMed
Wells PS, Anderson DR, Rodger M.  et al.  Derivation of a simple clinical model to categorize patients' probability of pulmonary embolism.  Thromb Haemost. 2000;83(3):416-420
PubMed
Schoepf UJ, Goldhaber SZ, Costello P. Spiral computed tomography for acute pulmonary embolism.  Circulation. 2004;109(18):2160-2167
PubMed
Drucker EA, Rivittz SM, Shepard JA.  et al.  Acute pulmonary embolism: assessment of helical CT for diagnosis.  Radiology. 1998;209(1):235-241
PubMed
van Rossum AB, van Erkel AR, van Persijn van Meerten EL.  et al.  Accuracy of helical CT for pulmonary embolism: ROC analysis of observer performance related to clinical experience.  Eur Radiol. 1998;8(7):1160-1164
PubMed
Rathbun SW, Raskob GE, Whitsett TL. Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review.  Ann Intern Med. 2000;132(3)227-232
PubMed
Schoepf UJ, Costello P. CT angiography for diagnosis of pulmonary embolism: state of the art.  Radiology. 2004;230(2):329-337
PubMed
Ghaye B, Ghuysen A, Willems V.  et al.  Severe pulmonary embolism: pulmonary clot load scores and cardiovascular parameters as predictors of mortality.  Radiology. 2006;239(3):884-891
PubMed
Parker MS, Hui FK, Camacho MA.  et al.  Female breast irradiation exposure during CT pulmonary angiography.  AJR Am J Roentgenol. 2005;185(5):1228-1233
PubMed
Stein PD, Henry JW. Prevalence of acute pulmonary embolism in central and subsegmental pulmonary arteries and relation to probability interpretation of ventilation perfusion lung scans.  Chest. 1997;111(5):1246-1248
PubMed
Remy-Jardin M, Pistolesi M, Goodman LR.  et al.  Management of suspected acute pulmonary embolism in an era of CT angiography: a statement of the Fleischner Society.  Radiology. 2007;245(2):315-329
PubMed
Le Gal G, Righini M, Parent F, Van Strijens M, Couturaud F. Diagnosis and management of subsegmental pulmonary embolism.  J Thromb Haemost. 2006;4(4):724-731
PubMed
Sijens PE, van Ingen HE, van Beek EJ, Berghout A, Oudkerk M. Rapid ELISA assay for plasma D-dimer in the diagnosis of segmental and subsegmental pulmonary embolism: a comparison with pulmonary angiography.  Thromb Haemost. 2000;84(2):156-159
PubMed
Goodman LR. Small pulmonary emboli: what do we know?  Radiology. 2005;234(3):654-658
PubMed
Rodger MA, Bredeson CN, Jones G.  et al.  The bedside investigation of pulmonary embolism diagnosis study: a double-blind randomized controlled trial comparing combinations of 3 bedside tests vs ventilation-perfusion scan for the initial investigation of suspected pulmonary embolism.  Arch Intern Med. 2006;166(2):181-187
PubMed
Robin ED. Overdiagnosis and overtreatment of pulmonary embolism: the emperor may have no clothes.  Ann Intern Med. 1977;87(6):775-781
PubMed

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Anderson DR, Kahn SR, Rodger MA.  et al.  Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial.  JAMA. 2007;298(23):2743-2753
Eng J, Krishnan JA, Segal JB.  et al.  Accuracy of CT in the diagnosis of pulmonary embolism: a systematic literature review.  AJR Am J Roentgenol. 2004;183(6):1819-1827
PubMed
Strashun AM. A reduced role of V/Q scintigraphy in the diagnosis of acute pulmonary embolism.  J Nucl Med. 2007;48(9):1405-1407
PubMed
Stein PD, Hull RD, Patel KC.  et al.  D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review.  Ann Intern Med. 2004;140(8):589-602
PubMed
Wells PS, Anderson DR, Rodger M.  et al.  Derivation of a simple clinical model to categorize patients' probability of pulmonary embolism.  Thromb Haemost. 2000;83(3):416-420
PubMed
Schoepf UJ, Goldhaber SZ, Costello P. Spiral computed tomography for acute pulmonary embolism.  Circulation. 2004;109(18):2160-2167
PubMed
Drucker EA, Rivittz SM, Shepard JA.  et al.  Acute pulmonary embolism: assessment of helical CT for diagnosis.  Radiology. 1998;209(1):235-241
PubMed
van Rossum AB, van Erkel AR, van Persijn van Meerten EL.  et al.  Accuracy of helical CT for pulmonary embolism: ROC analysis of observer performance related to clinical experience.  Eur Radiol. 1998;8(7):1160-1164
PubMed
Rathbun SW, Raskob GE, Whitsett TL. Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review.  Ann Intern Med. 2000;132(3)227-232
PubMed
Schoepf UJ, Costello P. CT angiography for diagnosis of pulmonary embolism: state of the art.  Radiology. 2004;230(2):329-337
PubMed
Ghaye B, Ghuysen A, Willems V.  et al.  Severe pulmonary embolism: pulmonary clot load scores and cardiovascular parameters as predictors of mortality.  Radiology. 2006;239(3):884-891
PubMed
Parker MS, Hui FK, Camacho MA.  et al.  Female breast irradiation exposure during CT pulmonary angiography.  AJR Am J Roentgenol. 2005;185(5):1228-1233
PubMed
Stein PD, Henry JW. Prevalence of acute pulmonary embolism in central and subsegmental pulmonary arteries and relation to probability interpretation of ventilation perfusion lung scans.  Chest. 1997;111(5):1246-1248
PubMed
Remy-Jardin M, Pistolesi M, Goodman LR.  et al.  Management of suspected acute pulmonary embolism in an era of CT angiography: a statement of the Fleischner Society.  Radiology. 2007;245(2):315-329
PubMed
Le Gal G, Righini M, Parent F, Van Strijens M, Couturaud F. Diagnosis and management of subsegmental pulmonary embolism.  J Thromb Haemost. 2006;4(4):724-731
PubMed
Sijens PE, van Ingen HE, van Beek EJ, Berghout A, Oudkerk M. Rapid ELISA assay for plasma D-dimer in the diagnosis of segmental and subsegmental pulmonary embolism: a comparison with pulmonary angiography.  Thromb Haemost. 2000;84(2):156-159
PubMed
Goodman LR. Small pulmonary emboli: what do we know?  Radiology. 2005;234(3):654-658
PubMed
Rodger MA, Bredeson CN, Jones G.  et al.  The bedside investigation of pulmonary embolism diagnosis study: a double-blind randomized controlled trial comparing combinations of 3 bedside tests vs ventilation-perfusion scan for the initial investigation of suspected pulmonary embolism.  Arch Intern Med. 2006;166(2):181-187
PubMed
Robin ED. Overdiagnosis and overtreatment of pulmonary embolism: the emperor may have no clothes.  Ann Intern Med. 1977;87(6):775-781
PubMed
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
JAMAevidence.com

Users' Guides to the Medical Literature
Thromboembolism or Acute Pulmonary Embolism

Users' Guides to the Medical Literature
Table 9.2-3 Refuted Evidence From Observational Studiesa